Brief: Bergenbio Q1 Operating Loss Widens To NOK 83.4 Mln
May 19 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO ASA: RESULTS FOR THE FIRST QUARTER 2021
* Q1 OPERATING LOSS OF NOK 83.4 MILLION (NOK 56.2 MILLION)
* Q1 REVENUE AMOUNTED TO NOK 0.0 MILLION (NOK 0.0 MILLION)
Source text for Eikon: ID:nWkr6SgTvB
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee